Published by Josh White on 20th May 2024
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American depositary share (ADS).
URL: http://www.digitallook.com/dl/news/story/34303202/...